Loading data
CHKPNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2.73 bn USD | 2.57 bn USD | 2.41 bn USD | 2.33 bn USD | 2.17 bn USD |
| Cost of revenue | 361.8 m USD | 319.3 m USD | 282.6 m USD | 304.4 m USD | 258.1 m USD |
| Research and development expense | 456.7 m USD | 394.9 m USD | 368.9 m USD | 349.9 m USD | 292.7 m USD |
| Operating profit | 831.1 m USD | 876 m USD | 899.1 m USD | 884.3 m USD | 907.5 m USD |
| Profit before tax | 945.1 m USD | 972.1 m USD | 975.6 m USD | 928.3 m USD | 949.6 m USD |
| Income tax expense | -111.8 m USD | 126.4 m USD | 135.3 m USD | 131.4 m USD | 134 m USD |
| Net income (reported basis) | 1.06 bn USD | 845.7 m USD | 840.3 m USD | 796.9 m USD | 815.6 m USD |
| Basic earnings per share | 9.85 USD/share | 7.65 USD/share | 7.19 USD/share | 6.37 USD/share | 6.13 USD/share |
| Diluted earnings per share | 9.62 USD/share | 7.46 USD/share | 7.1 USD/share | 6.31 USD/share | 6.08 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.